-
Indices from Asia-Pacific traded mixed during the first session of a new week - Nikkei and Kospi gained 0.3% each, Nifty 50 added 0.2%, S&P/ASX 200 dropped 0.3% and indices from China traded down as much as 1%
-
US and European index futures are trading little changed at the beginning of a new week
-
The People's Bank of China cut the 1-year lending rate from 3.55% to 3.45% while the 5-year rate was left unchanged at 4.20%. This is a disappointment as market expected 15 bp rate cuts to both rates in an attempt to prop up ailing Chinese economy
-
The United States gave the green light for the transfer of F-16 fighter jets to Ukraine. The Netherlands and Denmark have already announced they will transfer around 60 aircraft combined
-
Decision to transfer F-16s to Ukraine has been strongly criticized by Russia and threatened to respond with stiff measures due to F-16s capability to carry nuclear weapons.
-
Nomura cut its forecast for China's GDP growth in 2023 from 5.1 to 4.6%, citing weak data for July as a reason. Forecast for 2024 was left unchanged at 3.9%
-
Japan decided to boost minimum hourly wage by around 4.2% in fiscal-2023, up from an around 3.3% increase in previous year
-
New Zealand's trade balance came in at -NZ$1.107 billion in July (exp. +NZ$0.05 billion), as exports plunged while imports increased
-
Cryptocurrencies are trading mixed today with Bitcoin dropping 0.2% at press time and Dogecoin adding 0.1%
-
Energy commodities trade higher today - oil trades 0.7% higher while US natural gas prices rise 0.8%
-
Precious metals trade a touch higher today - gold and platinum gain 0.1% while silver trades 0.3% higher
-
EUR and GBP are the best performing major currencies while NZD and AUD lag the most
Chinese equities lagged regional peers today following a smaller-than-expected rate cut delivered by People's Bank of China. CHNComp has even briefly traded below 6,031 pts, reaching the lowest level since late-November 2022. Source: xStation5
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appThe material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.